Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |